Day: May 25, 2023

Dizal’s Oncology Pipeline Continues to Impress with Two Oral Presentations at 2023 ASCO Annual Meeting

SHANGHAI, May 26, 2023 /PRNewswire/ — Dizal (688192.SH) today announced that data from its oncology portfolio will be presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2-6, 2023 in Chicago. The data which include updated analyses of Dizal’s two leading assets – sunvozertinib (a selective EGFR TKI targeting a wide […]

Daewoong Pharmaceutical Publishes Molecular Mechanism of Bersiporocin as an Antifibrotic in EMBO Molecular Medicine

Elucidated molecular mechanism behind safety and efficacy of Bersiporocin Bersiporocin is currently in Phase II clinical trial for Idiopathic Pulmonary Fibrosis SEOUL, South Korea, May 26, 2023 /PRNewswire/ — Daewoong Pharmaceutical (CEO Lee Chang-jae and Jeon Sengho) announced on the 25th that the molecular mechanism behind safety and efficacy of Bersiporocin as an antifibrotic for […]

Invivoscribe Announces Updated Reimbursement for the LeukoStrat CDx FLT3 Mutation Assay to Select Newly Diagnosed FLT3-ITD Positive AML Patients Eligible for VANFLYTA in Japan

SAN DIEGO, May 26, 2023 /PRNewswire/ — Invivoscribe is pleased to announce that their LeukoStrat CDx FLT3 Mutation Assay® has received updated reimbursement by Japan’s Ministry of Health, Labor and Welfare (MHLW) to aid in the selection of patients with newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) who may be eligible to receive treatment […]

I-Mab Announces Encouraging Phase 1b/2 Study Results of Patients with Advanced NSCLC Receiving Uliledlimab and Toripalimab Combination Therapy at ASCO 2023

–  Uliledlimab is a differentiated monoclonal antibody designed to target CD73 and promote stronger activation of patients’ immune system against cancer cells. –  In newly diagnosed patients who were not eligible for or declined chemotherapy treatment, 63% of the patients with CD73High and PD-L1 TPS≥1% responded to the combination therapy while the response rate was 31% […]

Lunit Demonstrates Predictive Value of AI-Biomarker Platform at the 2023 ASCO Annual Meeting

– New studies reveal Lunit SCOPE’s impact on predicting clinical outcomes, analyzing tumor microenvironment, and enhancing personalized cancer treatment SEOUL, South Korea, May 26, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics solutions, is set to make a significant impact at the American Society of Clinical Oncology (ASCO) Annual Meeting […]

Deltek Reaches Agreement to Acquire Replicon, A Global Provider of Knowledge Workforce Management Solutions for Project and Service-Centric Organizations

HERNDON, Va., May 26, 2023 /PRNewswire/ — Deltek, the leading global provider of software and solutions for project-based businesses, announced today that it has entered into an agreement to acquire Replicon – a provider of unified time tracking solutions that bring together Project Delivery, Finance and HR on a single platform, purpose-built for project and […]


Join the waitlist today to be the first to know when tickets go on sale. MACAO, May 26, 2023 /PRNewswire/ — Imagine Exhibitions in partnership with Warner Bros. Discovery Global Themed Entertainment and EMC Presents, have announced Harry Potter™: The Exhibition, the most comprehensive touring exhibition ever presented about the Wizarding World, will host its Asia […]

Back To Top